Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca PLC's Subsidiary Receives Patent Grant for Form of S-omeprazole-US Federal News

Wednesday, 19 Jun 2013 08:00pm EDT 

US Federal News reported that United States Patent no.8,466,175, issued on June 18, 2013 was assigned to AstraZeneca AB, a subsidiary of AstraZeneca PLC. The patent was issued for Form of S-omeprazole. 

Company Quote

38.0 +0.83%
19 Dec 2014